The company, which plans to liquidate, has $1.3 million in assets and nearly $257 million in liabilities owed to lenders, investors, vendors and employees, according to court filings.
With Amazon Clinic, patients can see wait times and prices upfront, but there are limits to what it can do to cut down on the $4.3 trillion the U.S. spends on healthcare.
There are more than 50,000 venture-backed startups in the U.S., and only the tiniest fraction will ever reach a $1 billion valuation. Here are the 25 we think most likely to succeed.
Biotech researcher Colleen Cutcliffe designed probiotics to help diabetics lower their blood sugar. Now she’s got a handful of expensive supplements for sale — and Halle Berry on board to help sell them.
OpenEvidence, which is valued at $425 million, is taking on one of AI’s big engineering challenges: large language models whose training is stuck in the past.
Benjamin Oakes’ Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion
With a new $59 million investment, digital health startup K Health is looking to scale its AI technology in hospitals, starting with new strategic investor Cedars-Sinai.